In order to expand the business of traditional Chinese medicine formula granules, a pharmaceutical company has obtained more than 200 listing filing certificates

【Pharmaceutical Network Enterprise News】Recently, Jilin Ao Dong issued an announcement that 6 products of Yanbian Pharmaceutical, a holding subsidiary, obtained the "Chinese Medicine Formula Granules Market Filing Certificate"
.
According to the announcement, the products that obtained the "Chinese Medicine Formula Granules Market Filing Certificate" this time are Qingpi (individual green peel) formula granules, wine huanglian (huanglian) formula granules, jingji mustard formula granules, vinegar green peel (four-flower green peel) formula granules, fried hawthorn (mountain red) formula granules, and Jiuchuan hyssop formula granules
.
In fact, since the beginning of this year, Yanbian Pharmaceutical has obtained a number of batches of products from the "Listing Filing Certificate of Traditional Chinese Medicine Formula Granules"
.
In May, Jilin Ao Dong received 25 "Chinese Medicine Formula Granules Market Filing Certificates"
for Yanbian Pharmaceutical.
Prior to this, on February 8, Jilin Ao Dong issued an announcement that Yanbian Pharmaceutical, a holding subsidiary, received eight national standards for the listing of traditional Chinese medicine formula granules, including angelica formula granules, wine salvia formula granules, etc
.
In January this year, Yanbian Pharmaceutical also obtained 91 Chinese medicine formula granules for the record, involving varieties including raw rehmannia formula granules and lotus leaf formula granules
.
Jilin Ao Dong said that Yanbian Pharmaceutical, as a core enterprise, has certain advantages
in the field of traditional Chinese medicine.
As of the announcement date, a total of 208 "Chinese Medicine Formula Granules Market Filing Certificates" have been obtained, which is of great significance to expanding the business of Chinese medicine formula granules, and will also create favorable conditions for the sustainable development of the company and further enhance the core competitiveness
of the enterprise.
It is understood that the Chinese medicine industry includes three pillar industries
: Chinese herbal medicines, Chinese medicine pieces and proprietary Chinese medicines.
Among them, the Chinese medicine formula granules are granules that are further extracted and concentrated from Chinese herbal medicines, which have the advantages
of no need for decoction, hygiene and convenience.
With many advantages, TCM formula granules are currently widely used, and the market is also expanding
.
At the same time, the state and local governments have also successively issued policies to promote the standardization process and research of
the traditional Chinese medicine formula granule industry.
Among them, it is worth mentioning that on February 10, 2021 this year, the State Food and Drug Administration announced the "Announcement on Ending the Pilot Work of Traditional Chinese Medicine Formula Granules"
jointly issued by the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine, the National Health Commission and the National Medical Insurance Administration.
According to the announcement, after research, it was decided to end the pilot work of traditional Chinese medicine formula granules, implement recordal management of varieties of traditional Chinese medicine formula granules, and do not implement the management of approval numbers, and the manufacturer will report to the local provincial drug regulatory department for the record before marketing, which will come into effect
on November 1, 2021.
On this basis, the State Food and Drug Administration also issued the Notice on Matters Related to the Filing of Traditional Chinese Medicine Formula Granules
.
The notice requires that from November 1, 2021, the varieties of Chinese medicine formula granules will be subject to recordal management, and before they are put on sale, they need to be filed with the State Food and Drug Administration to obtain a filing number
.
The industry believes that the quality and standards of traditional Chinese medicine formula granules have always been the focus of the industry, and the construction process of relevant national standards has been accelerating in recent years
.
In the future, with the continuous advancement of the construction process of relevant standards for traditional Chinese medicine formula granules, and the successive efforts of provincial drug regulatory departments to formulate and release relevant standards for traditional Chinese medicine formula granules, the market space of traditional Chinese medicine formula granules will become larger and larger under the background of continuous development in the direction of standardization, and related pharmaceutical companies will also usher in major benefits
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.